Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

AT7519

Product Specifications

UNSPSC Description

AT7519 (AT7519M) as a potent inhibitor of CDKs, with IC50s of 210, 47, 100, 13, 170, and <10 nM for CDK1, CDK2, CDK4 to CDK6, and CDK9, respectively.

Target Antigen

Apoptosis; CDK

Type

Reference compound

Related Pathways

Apoptosis;Cell Cycle/DNA Damage

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/at7519.html

Purity

99.76

Solubility

DMSO : ≥ 50 mg/mL

Smiles

O=C(NC1=CNN=C1C(NC2CCNCC2)=O)C3=C(Cl)C=CC=C3Cl

Molecular Weight

382.24448

References & Citations

[1]Santo L, et al. AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibition. Oncogene. 2010 Apr 22;29(16):2325-36.|[2]Squires MS, et al. Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines. Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines.|[3]Squires MS, et al. AT7519, a cyclin-dependent kinase inhibitor, exerts its effects by transcriptional inhibition in leukemia cell lines and patient samples. Mol Cancer Ther. 2010 Apr;9(4):920-8.Adv Sci (Weinh). 2024 Jan 6:e2305260.|bioRxiv. 2024 September 07.|Dev Biol. 2024 Jan 28:508:93-106.|Exp Eye Res. 2023 Jan 22;227:109391.|FASEB J. 2024 Apr 30;38(8):e23628.|Glycobiology. 2022 Jun 16;cwac038.|Harvard Medical School LINCS LIBRARY|Oncogene. 2023 Oct 16.|RNA Biol. 2021 Sep 30;1-8.|Sci Rep. 2021 Mar 8;11(1):5374.|Sci Transl Med. 2018 Jul 18;10(450):eaaq1093.|Cell Chem Biol. 2018 Feb 15;25(2):135-142.e5.|Harvard Medical School LINCS LIBRARY

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-50940/AT7519-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-50940/AT7519-SDS-MedChemExpress.pdf

Clinical Information

Phase 2

CAS Number

844442-38-2

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Mast1 ORF Vector (Mouse) (pORF)
28136014 1.0 µg DNA

Mast1 ORF Vector (Mouse) (pORF)

Ask
View Details
ARSE Antibody
A24255-100UG 100 µg

ARSE Antibody

Ask
View Details
Recombinant Mycobacterium bovis Proline-rich 28 kDa antigen (mtc28)
MBS1227988-01 0.02 mg (E-Coli)

Recombinant Mycobacterium bovis Proline-rich 28 kDa antigen (mtc28)

Ask
View Details
Recombinant Mycobacterium bovis Proline-rich 28 kDa antigen (mtc28)
MBS1227988-02 0.02 mg (Yeast)

Recombinant Mycobacterium bovis Proline-rich 28 kDa antigen (mtc28)

Ask
View Details
Recombinant Mycobacterium bovis Proline-rich 28 kDa antigen (mtc28)
MBS1227988-03 0.1 mg (E-Coli)

Recombinant Mycobacterium bovis Proline-rich 28 kDa antigen (mtc28)

Ask
View Details
Recombinant Mycobacterium bovis Proline-rich 28 kDa antigen (mtc28)
MBS1227988-04 0.1 mg (Yeast)

Recombinant Mycobacterium bovis Proline-rich 28 kDa antigen (mtc28)

Ask
View Details